How to Source Imipenem + Cilastatin Powder for Reconstitution for Pharmaceutical Formulation
Imipenem + Cilastatin Powder for Reconstitution (Powder for Reconstitution, 500 mg/500 mg, 1 g/1 g in vials) is classified under Antibiotics. It is therapeutically aligned with reference brands such as Primaxin, Gemax (US & EU). This guide highlights key sourcing factors buyers should consider when procuring high-quality Imipenem + Cilastatin Powder for Reconstitution for formulation, R&D, or bulk manufacturing.
Product Overview:
Imipenem + Cilastatin inhibits bacterial cell wall synthesis by targeting penicillin-binding proteins, causing bacterial lysis. Cilastatin prevents renal degradation of imipenem, prolonging its activity. Benefits include rapid, broad-spectrum action against resistant bacteria, effective in severe infections like pneumonia and sepsis, and reliable bacterial eradication when used appropriately in clinical settings.
Imipenem + Cilastatin powder for reconstitution is approved in the EU and US for treating severe bac...
Imipenem + Cilastatin Powder for Reconstitution API – ideal for compliant pharmaceutical formulation.
Quick Insight: Over 60% of formulation delays are linked to poor API sourcing. A well-planned sourcing strategy can reduce risk and accelerate market entry.
1. Regulatory Compliance & Documentation
Ensure suppliers provide:
- ✔ Valid DMF (Drug Master File)
- ✔ COA (Certificate of Analysis) for each batch
- ✔ GMP, ISO, or ICH Q7 compliance certificates
2. Purity, Grade & Specification Matching
Imipenem + Cilastatin Powder for Reconstitution must meet exact grade and purity for your dosage form:
- ✔ USP / EP / JP grade verification
- ✔ Particle size distribution check
- ✔ Residual solvent and heavy metal limits
3. Supplier Reliability & Audit History
- ✔ Positive past audit reports
- ✔ Pharma client references
- ✔ Years of proven API manufacturing experience
4. Commercial Terms: Pricing, MOQ & Flexibility
- ✔ Transparent pricing
- ✔ Pilot batch MOQ flexibility
- ✔ Volume-based discounts
5. Lead Time, Inventory & Logistics
Typical lead time for Imipenem + Cilastatin Powder for Reconstitution is 4–6 weeks.
- ✔ Emergency dispatch options
- ✔ Regional warehousing
- ✔ Special storage if needed
6. Formulation Support
- ✔ Technical datasheets
- ✔ Sample availability
- ✔ Stability study support
Pro Tip: Engage supplier formulation experts early — it can improve bioavailability and cut development time.
Conclusion
Sourcing Imipenem + Cilastatin Powder for Reconstitution is more than procurement—it’s a strategic partnership. With its powder for reconstitution form and 500 mg/500 mg, 1 g/1 g in vials specification, choosing a compliant supplier ensures consistent quality and regulatory approval. Prioritize documentation, verify compatibility, and build relationships with transparent, reliable suppliers to secure long-term success.
Next Step: Get expert assistance in sourcing Imipenem + Cilastatin Powder for Reconstitution.
Request a Quote
Frequently Asked Questions For Sourcing of Imipenem + Cilastatin Powder for Reconstitution
What is the typical lead time for Imipenem + Cilastatin Powder for Reconstitution?
Lead times range from 4–6 weeks depending on supplier and region.
Is Imipenem + Cilastatin Powder for Reconstitution available in multiple grades?
Yes — common grades include USP, EP, and JP. Verify grade suitability for your dosage form before purchase.
Does Imipenem + Cilastatin Powder for Reconstitution require special storage?
It should be stored in a cool, dry place away from direct sunlight.
Is a Drug Master File (DMF) available for Imipenem + Cilastatin Powder for Reconstitution?
Yes, a DMF is available for regulated markets upon request. It includes detailed quality, manufacturing, and stability data.
Can I request samples or a pilot batch of Imipenem + Cilastatin Powder for Reconstitution?
Yes — pilot batches or samples can be arranged for R&D, stability studies, or formulation trials. MOQ may vary based on region and regulatory scope.
What compliance certificates are available for Imipenem + Cilastatin Powder for Reconstitution?
Available documentation may include GMP, ISO 9001, ISO 14001, and ICH Q7 certificates, along with CoA, TDS, and stability data.
Is Imipenem + Cilastatin Powder for Reconstitution suitable for regulated markets like US/EU?
Yes — compliant with EU/US/WHO GMP standards and available with regulatory support documentation for filings.
Can Imipenem + Cilastatin Powder for Reconstitution be used in fixed-dose combinations?
Yes — many formulations support inclusion in FDCs. Compatibility studies and formulation consultation are available on request.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our
Privacy Policy.